Brain Health

Additionally, the authors observe that childhood-onset epilepsy is associated with an earlier age at the onset of amyloidosis.

Administered every 4 weeks, the approval could serve as a breakthrough for easier and more effective care for patients with early Alzheimer disease.

Based on the updated label, new pharmacodynamic data have been added for a better understanding of the drug for individuals with attention-deficit/hyperactivity disorder (ADHD).

Pharmacists bridge communication gaps and enhance shared decision-making.

Despite these findings, navacaprant was generally well-tolerated and safe in patients with major depressive disorder.

Memantine/donepezil and everolimus are used to treat dementia of the Alzheimer type and tuberous sclerosis complex-associated subependymal giant cell astrocytoma, respectively.

The study found that internalizing and externalizing factors, brain maturation, and decreasing volumes of brain regions were linked to eating disorders.

Esketamine targets glutamate, the most abundant neurotransmitters in the brain.

The authors note that future research will observe personality changes when psilocybin is used in patients with opioid-use disorder.

The test meets a critical unmet need for patients with Alzheimer disease who have not yet been undiagnosed.

Hokkaido scallop oil plasmalogen and Apoaequorin have both been posited to improve brain health.

The pharmacist’s role includes educating and making recommendations, collaborating with health care professionals, and observing early signs of cognitive impairment in patients during interactions.

These inequalities, which can include socioeconomic disparities, show neurological changes associated with aging and dementia.

Although each of the product samples of phenibut contained the actual active ingredient, the exact amount of the active ingredient was inaccurate and, in one sample, found to be at a higher dose.

Female adolescents were at an increased risk of experiencing depression and anxiety symptoms compared with males.

The findings show a need for researchers and health care professionals to consider model designs to minimize disparities when diagnosing perinatal mood and anxiety disorders (PMADs).

The investigators also find that age of initiation and frequent use were not associated with a greater age-related cognitive decline.

Pharmacists can make a significant impact by providing medication management, promoting nonpharmacologic approaches, supporting patients through life transitions.

Adults with epilepsy are underrepresented in most CBD trials, including common etiologies.

Brain Health is an emerging research topic, but there is not a standard outcome measure.

Children born moderate to late preterm also showed more behavior difficulties compared with those born early term or later.

The authors recommend that longer assessments with lengthier interventions should be performed to assess potential benefits.

Postpartum depression (PPD) rates also had notable increases in those with class I and class II/III obesity.

If approved, RAG-21 can offer improved outcomes in patients with amyotrophic lateral sclerosis (ALS), particularly those with aggressive subtypes.

Policies that focus on earlier diagnosis, treatment initiation, and expanded access to treatment can further improve treatment and health equity impacts.